Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling…
Pharmaceuticals, Biotechnology and Life Sciences
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling…
Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small…
An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth.…
COVID-19 is the medical emergency of the century. Since the pandemic began in December 2019, the new coronavirus, termed SARS-CoV-2 has caused havoc in almost every country, with more than 40 million proven cases of the disease termed COVID-19, including one million deaths.
The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about testing:
FDA Provides Free Method to Obtain Informed Consent Electronically for Eligible Clinical Trials During the COVID-19 Public Health Emergency The…
the digital coach from Nori Health is made available for free from their website (use access code UKFREE) with the support of the Primary Care Society for Gastroenterology and its Chair, Dr Kevin Barrett.
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–Infiniti Research is a leading provider of market intelligence services to businesses around the globe. For over 15 years,…
Companies selling personal protective equipment like face masks and gloves seem to be having a hard time getting their products to their target audience, no thanks to the practices of online platforms such as search engines, online stores, and social media networking sites.
GeneMe, a leading biotech company based in Gdańsk, Poland has developed “FRANKD” – a fast, scalable and reliable mouth swab test for COVID-19 that is completed on-premises in on average 13-25 minutes with no laboratory involvement.